ADIPOQ and Insulin resistance: The persistent downregulation of ADIPOQ in STEMI patients suggests impaired adipose tissue function and dysregulated adipokine secretion, contributing to systemic inflammation, insulin resistance, and endothelial dysfunction observed in acute myocardial infarction [42].